Cubist Systematic Strategies, LLC Igm Biosciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.51 - $11.47 $21,483 - $37,851	3,300 New	3,300 $22,000
Q2 2023 Aug 14, 2023	BUY	$8.86 - $14.0 $73,635 - $116,354	8,311 Added 379.67%	10,500 $96,000
Q1 2023 May 15, 2023	BUY	$13.74 - $25.76 $30,076 - $56,388	2,189 New	2,189 $30,000
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $40,076 - $70,198	-2,599 Reduced 11.6%	19,801 $450,000
Q2 2022 Aug 15, 2022	BUY	$13.27 - $25.5 $187,014 - $359,371	14,093 Added 169.65%	22,400 $404,000
Q1 2022 May 16, 2022	SELL	$13.42 - $29.73 $337,378 - $747,412	-25,140 Reduced 75.16%	8,307 $222,000
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $768,629 - $1.85 Million	27,859 Added 498.55%	33,447 $981,000
Q3 2021 Nov 15, 2021	BUY	$65.76 - $90.65 $367,466 - $506,552	5,588 New	5,588 $367,000
Q2 2021 Aug 16, 2021	SELL	$57.98 - $96.6 $306,366 - $510,434	-5,284 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$71.56 - $121.23 $166,162 - $281,496	-2,322 Reduced 30.53%	5,284 $405,000
Q4 2020 Feb 16, 2021	BUY	$47.41 - $115.03 $162,379 - $393,977	3,425 Added 81.92%	7,606 $672,000
Q3 2020 Nov 16, 2020	BUY	$43.0 - $84.01 $179,783 - $351,245	4,181 New	4,181 $309,000
Q4 2019 Feb 14, 2020	SELL	$17.25 - $49.51 $91,528 - $262,700	-5,306 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$17.75 - $24.3 $94,181 - $128,935	5,306 New	5,306 $94,000

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $189M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.